Title: Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy
Authors: de Haas, Sanne ×
Delmar, Paul
Bansal, Aruna T
Moisse, Matthieu
Miles, David W
Leighl, Natasha
Escudier, Bernard
Van Cutsem, Eric
Carmeliet, Peter
Scherer, Stefan J
Pallaud, Celine
Lambrechts, Diether #
Issue Date: Oct-2014
Publisher: Rapid Science Publishers
Series Title: Angiogenesis vol:17 issue:4 pages:909-20
Article number: 10.1007/s10456-014-9438-1
Abstract: Despite extensive translational research, no validated biomarkers predictive of bevacizumab treatment outcome have been identified.
ISSN: 0969-6970
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Translational Genetics (Vesalius Research Center) (+)
Clinical Digestive Oncology (+)
Laboratory of Angiogenesis and Vascular Metabolism (VIB-KU Leuven Centre for Cancer Biology) (+)
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
GenVar of VEGF_De Haas et al.pdfOA article Published 1110KbAdobe PDFView/Open


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science